Debiopharm Innovation Fund offers a strategic investments in for companies and businesses.
Business Model:
Revenue: $43.3M
Employees: 201-500
Address: Chemin Messidor 5-7
City: Lausanne
State: vaud
Zip: CH-1002
Country: CH
Debiopharm Innovation Fund invests in digital health companies that have an impact on cancer, infectious diseases, and drug development. We are looking for ambitious entrepreneurs raising series A or B with clinically proven, transformative technologies that use AI and data to help patients. We do not invest in consumer wellness or workflow solutions. Our initial investment is typically $2-5M. Along with capital we bring deep pharma knowledge &a; networks and long-term commitment to help build value in your company. We are an evergreen investment fund of the pharmaceutical company Debiopharm based in Lausanne, Switzerland.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
7/2020 | Nucleai | Series A | 0 |
2/2021 | Carevive Systems | Series C | 0 |
3/2022 | VivoSense | Series A | 0 |
5/2017 | BC Platforms | Series B | 10M |
11/2013 | Biocartis | Series E | 0 |
9/2020 | Oncomfort | Series A | 0 |
11/2014 | Coorpacademy | Series A | 4M |
3/2023 | Genialis | Series A | 0 |
5/2022 | Mika | Series A | 0 |
2/2020 | Carevive Systems | Series C | 0 |
11/2020 | Voluntis | Post-IPO Equity | - |
12/2019 | BC Platforms | Series C | 15M |
4/2018 | Kaiku Health | Series A | 5.4M |
11/2021 | Mekonos | Series A | 0 |
6/2005 | Neovacs | Venture Round | - |
10/2012 | Searchbox | Series B | - |
3/2022 | Nucleai | Series B | 0 |
1/2022 | VeriSIM Life | Series A | 0 |
2/2018 | ABAC Therapeutics | Series A | 0 |
11/2022 | YonaLink | Seed Round | 6M |
6/2013 | Diagnoplex | Venture Round | 1.4M |
9/2013 | KeyLemon | Series A | 1.5M |
5/2022 | Mika | Series A | 0 |
3/2022 | VivoSense | Series A | 0 |
3/2022 | Nucleai | Series B | 0 |
1/2022 | VeriSIM Life | Series A | 0 |
11/2021 | Mekonos | Series A | 0 |
2/2021 | Carevive Systems | Series C | 0 |
11/2020 | Voluntis | Post-IPO Equity | - |
9/2020 | Oncomfort | Series A | 0 |
7/2020 | Nucleai | Series A | 0 |
2/2020 | Carevive Systems | Series C | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|